Tesamorelin by Dragon Pharma

Dragon Pharma
Key Facts
ProductTesamorelinManufacturerDragon PharmaActive substanceTesamorelin (GHRH analog)Concentration5 mg per vialFormLyophilized peptide for injectionRouteSubcutaneous after reconstitutionBest forSleep, recovery rhythm, metabolic balance
Available Domestic
$70.00
$70.00
In Stock
Manufacturer Dragon Pharma
Brand Tesamorelin
Substance Tesamorelin
Concentration 5 mg
Pack Size vial
Shipping

What Is Tesamorelin?

Tesamorelin by Dragon Pharma is a 5 mg lyophilized vial of a growth hormone releasing hormone (GHRH) analog peptide. Instead of delivering growth hormone from the outside, tesamorelin works upstream: it signals the pituitary gland to release more of the body's own growth hormone, keeping the natural pulse pattern that the body already uses. That difference is why it sits in the peptide and recovery category rather than next to classic injectables.

In practice people turn to Tesamorelin for three outcomes: deeper sleep and a calmer overnight recovery feel, steadier energy through long training blocks, and support for metabolic rhythm and body composition during lean phases. It is a mild compound with a low reported side effect profile, which makes it a common choice for off-cycle, bridge and high-workload periods when recovery matters more than pushing heavy doses.

The product arrives as sterile lyophilized powder and is reconstituted with bacteriostatic water before subcutaneous injection. Tesamorelin from Dragon Pharma is a laboratory research peptide sold for research and product reference purposes only.

Tesamorelin Research Use

Tesamorelin follows standard lyophilized peptide handling. Reconstitute the 5 mg vial with 1 ml of bacteriostatic water for a 5 mg per ml stock, or use 2 ml for a 2.5 mg per ml solution if you prefer larger injection volumes. Inject subcutaneously into a pinched skin fold and rotate sites to keep local irritation low.

Handling stepDetail
Vial content5 mg tesamorelin, lyophilized powder
DiluentBacteriostatic water
Final concentration5 mg/ml with 1 ml, or 2.5 mg/ml with 2 ml
RouteSubcutaneous injection, rotated sites
StorageRefrigerate after mixing; protect from light

Reconstitution

Research protocols most often reference a single daily administration because tesamorelin acts on growth hormone pulses that occur every day. The commonly referenced range for endocrine signaling studies is below, with volumes shown for a 5 mg per ml reconstitution.

Research focusDaily doseInjection volume
Recovery rhythm support1 mg0.2 ml
Sleep and GH pulse emphasis1-2 mg0.2-0.4 ml
Body composition protocols2 mg0.4 ml

At a 1-2 mg per day reference, one 5 mg vial covers 3-5 days of study. Schedule the injection at the same time each day and avoid large carbohydrate meals right before dosing, because glucose can blunt the growth hormone response. Only trained personnel should handle research peptides.

Tesamorelin Stacks

In research settings Tesamorelin is usually paired with other growth hormone axis peptides or with recovery and metabolic products. Every partner below belongs to the same Dragon Pharma line, so the whole stack comes from one trusted source.

StackResearch goal
Tesamorelin + IpamorelinCombine a GHRH signal with a ghrelin-pathway pulse
Tesamorelin + SermorelinTwo GHRH analogs compared in one protocol
Tesamorelin + CJC-1295 no DAC/Ipamorelin 10mgReady dual secretagogue blend for GH axis work
Tesamorelin + EpitalonRecovery rhythm and circadian focus
Tesamorelin + DSIP 10 mgSleep architecture support alongside GH pulse work
Tesamorelin + SS-31 50mgMitochondrial energy and recovery depth
Tesamorelin + TB 500Structural recovery and tissue resilience
Tesamorelin + Tirze-Pep 10mgMetabolic balance during fat loss research

Tesamorelin Side Effects and Precautions

Tesamorelin is one of the milder growth hormone axis peptides, and most reported effects are local and temporary rather than systemic. Still, any research use should follow a clear protocol and clean technique.

  • Injection site reactions: mild redness, itching or tenderness right after the shot, usually settling within a day.
  • Transient flush or light-headedness: occasionally reported shortly after injection and generally short-lived.
  • Fluid retention feel: GH-related water shift can make hands or ankles feel fuller in some subjects.
  • Joint or muscle discomfort: reported in clinical use at higher daily amounts; usually mild and dose-related.
  • Blood glucose awareness: GH changes fuel metabolism, so timing meals around dosing matters in longer protocols.
Note: reconstitute only with sterile bacteriostatic water, refrigerate opened vials, and do not combine high tesamorelin amounts with strong exogenous growth hormone without a defined research plan.

For research purposes only. Tesamorelin by Dragon Pharma is a laboratory research peptide, not a medicine and not approved for human consumption. Store responsibly and follow your local laws.

What is tesamorelin?

Tesamorelin is a synthetic analog of growth hormone releasing hormone (GHRH), the signal that makes the pituitary release growth hormone. Tesamorelin by Dragon Pharma is supplied as a lyophilized research peptide in a 5 mg vial.

Is tesamorelin the same as HGH?

No. Growth hormone is given from the outside, while tesamorelin stimulates the body to release more of its own growth hormone in natural pulses. The two are different molecules and tesamorelin is not a substitute for GH in research protocols.

What is tesamorelin used for in research?

Tesamorelin is studied for its effects on the growth hormone axis, sleep quality, recovery rhythm and metabolic balance. Published work has looked at visceral fat and body composition outcomes over periods of several months.

How much tesamorelin do research protocols use?

The most commonly referenced daily amount is 1-2 mg injected once a day. At that range a 5 mg vial covers roughly 3-5 days of a study, so longer protocols need several vials.

How do I reconstitute the Tesamorelin 5 mg vial?

Add 1 ml of bacteriostatic water for a 5 mg per ml solution, or 2 ml for a 2.5 mg per ml solution. Swirl gently until the powder dissolves and keep the vial refrigerated after mixing.

How long does Tesamorelin take to show research results?

In published studies body composition and fat loss outcomes are usually assessed after 8-12 weeks of consistent daily dosing. Earlier changes in sleep quality and recovery are often reported in the first one to two weeks.

Does tesamorelin have side effects?

Reported effects are generally mild and include injection site reactions, transient flushing, fluid retention and occasional joint or muscle discomfort. Blood glucose can also shift because growth hormone changes fuel metabolism.

Is Tesamorelin or Ipamorelin better for research?

Tesamorelin works on the GHRH pathway while ipamorelin works on the ghrelin pathway, so the two are not direct alternatives. Many researchers study them together because the signals complement each other.

How should Tesamorelin be stored?

Keep the lyophilized vial cool and protected from light before mixing. After reconstitution with bacteriostatic water, store it refrigerated and use it within the window recommended for sterile peptide solutions.

Is Tesamorelin by Dragon Pharma legit?

Tesamorelin is a branded GHRH research peptide from the Dragon Pharma line sold through gasproids.com. It is shipped as a lyophilized research product and is not intended for human consumption.